secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2022-10-25T23:59:59+00:00
Accession:  0001157523-22-001382
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q3 sales $233M (-15% YoY), EPS $0.78; slashes FY2022 guidance
-------------------------------------------------------------------

- Net sales $233M, down 15% YoY ($274M); diluted EPS $0.78 vs $1.36, down 43%.
- Active customers fell 18% to 474,000; Asia Pacific region sales down 17% constant currency.
- FY2022 outlook cut: net sales $955-975M (prev. $1,015-1,065M); EPS $3.15-3.40 (prev. $3.85-4.45).
- Operating cash flow $29M; cash $247M, debt-free; no share repurchases in quarter.
- Management cites COVID disruptions in Asia, stronger USD headwind of ~$15M (6% of sales).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000115752322001382/0001157523-22-001382-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000115752322001382/a52952545.htm
  HTML page:      https://secwatch.observer/filing/0001157523-22-001382

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer